Get updates to this list email feed

Copy and paste this URL in to your feed reader

  1. ACMD letter to the Home Secretary: invitation to the drug strategy board

    • Published
    • Correspondence
    • ACMD
  2. ACMD members' register of interests

    • Updated
    • Corporate report
    • ACMD
  3. ACMD warns ministers of falling local funding for drug treatment services

    • Published
    • News story
    • ACMD
  4. Commissioning impact on drug treatment

    • Published
    • Corporate report
    • ACMD
  5. Image and Performance Enhancing Drugs: public evidence gathering day

    • Published
    • News story
    • ACMD
  6. Home Office Science non-departmental public bodies (NDPBs): triennial review

    • Published
    • Corporate report
    • Home Office, ACMD, NDNAD, ASC and Biometrics and Forensics Ethics Group
  7. Psychoactive Substances Bill: evaluation review

    • Published
    • Corporate report
    • ACMD
  8. Drug strategy 2016: development review

    • Published
    • Corporate report
    • ACMD
  9. Methiopropamine: a review of the evidence of use and harm

    • Published
    • Corporate report
    • ACMD
  10. Now recruiting: Advisory Council on the Misuse of Drugs members

    • Published
    • News story
    • ACMD
  11. Methylphenidate-based novel psychoactive substances: temporary class drug order recommendations

    • Updated
    • Policy paper
    • ACMD
  12. Further advice on U-47,700, etizolam and other designer benzodiazepines

    • Updated
    • Correspondence
    • Home Office and ACMD
  13. Prescribing of controlled drugs by therapeutic radiographers: further advice

    • Published
    • Correspondence
    • ACMD
  14. Advice on U-47,700, etizolam and other designer benzodiazepines

    • Updated
    • Correspondence
    • ACMD
  15. Letter from Sarah Newton: U-47,700 and designer benzodiazepines

    • Published
    • Correspondence
    • ACMD
  16. Misuse of Drugs Regulations 2001: impact on research

    • Published
    • Correspondence
    • ACMD
  17. Plant cannabinoids: ACMD report

    • Published
    • Policy paper
    • ACMD
  18. Medicines supplementing use of other illicit drugs, says ACMD

    • Published
    • Press release
    • ACMD
  19. Diversion & illicit supply of medicines

    • Published
    • Policy paper
    • ACMD
  20. New chair of Advisory Council on the Misuse of Drugs

    • Published
    • Press release
    • Home Office and ACMD
  21. ACMD tells ministers drug-related deaths will continue to rise if treatment programmes are not maintained

    • Published
    • Press release
    • ACMD
  22. Reducing opioid-related deaths in the UK

    • Published
    • Independent report
    • ACMD
  23. 'Third generation' synthetic cannabinoids

    • Updated
    • Correspondence
    • ACMD
  24. Temporary class drug order on methiopropamine

    • Published
    • Correspondence
    • ACMD
  25. Problems for Ageing Drug Users Working Group: public meeting invitation

    • Published
    • Promotional material
    • ACMD
  26. Independent prescribing of controlled drugs by therapeutic radiographers

    • Published
    • Correspondence
    • ACMD
  27. Advisory Council on the Misuse of Drugs recruiting new chair

    • Published
    • News story
    • ACMD
  28. ACMD work programme for 2016

    • Published
    • Correspondence
    • ACMD
  29. ACMD review of alkyl nitrites (poppers)

    • Published
    • Correspondence
    • ACMD
  30. Advice on the anticonvulsant drugs Pregabalin and Gabapentin

    • Published
    • Correspondence
    • ACMD
  31. Advice on the steroid Dienedione

    • Published
    • Correspondence
    • ACMD
  32. ACMD’s temporary class drug order report on Methiopropamine

    • Published
    • Correspondence
    • ACMD
  33. ACMD public meeting: 24 November 2015

    • Published
    • Form
    • ACMD
  34. Quality of treatment for heroin users under threat

    • Published
    • News story
    • ACMD
  35. ACMD’s final advice on definitions for the Psychoactive Substances Bill

    • Published
    • Correspondence
    • ACMD
  36. How can opioid substitution therapy be optimised to maximise recovery outcomes for service users?

    • Published
    • Policy paper
    • ACMD
  37. Ministerial response to ACMD report on cocaine misuse

    • Published
    • Correspondence
    • DH, Home Office and ACMD
  38. Ministerial response to ACMD report on nitrous oxide misuse

    • Published
    • Correspondence
    • DH, Home Office and ACMD
  39. ACMD interim advice: diversion and illicit supply of medicines

    • Published
    • Correspondence
    • ACMD
  40. ACMD advice about Northern Ireland’s continued maintenance of the Addicts Index

    • Published
    • Correspondence
    • ACMD